On 20 April 2015
Beryl Drugs will hold a meeting of the Board of Directors of the Company on 20 April 2015, to consider the Unaudited Financial Results for the quarter ended on 31 March 2015, and to take note of general disclosures of interest of Directors under section 184 (1) in form MBPPowered by Capital Market - Live News
